Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a new label 'Last Update Posted (Estimated)' and removes the old 'Last Update Posted' label. This is a minor presentation change and does not modify the study data or main content.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page shows an updated revision tag to v3.3.2 (with a date) and the previous v3.3.1 tag is removed, with no visible changes to the study details.SummaryDifference0.2%

- Check18 days agoChange DetectedThe revision label changed from v3.2.0 to v3.3.1 in the page footer; no other visible content or functional changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check26 days agoChange DetectedRemoved the government funding delay notice from the page. Core trial details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check40 days agoChange DetectedThe two screenshots show the same Study Details page for NCT04191304 with no additions or deletions observed. Core sections such as design, eligibility criteria, and location lists remain unchanged.SummaryDifference0.3%

- Check69 days agoChange DetectedVersion updated from v3.0.2 to v3.2.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.